Recombinant activated factor VII in paediatric cardiac surgery

Author： Egan Jonathan   Lammi Ahti   Schell David   Gillis Jonathan   Nunn Graham  

Publisher： Springer Publishing Company

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.30, Iss.4, 2004-04, pp. : 682-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 2, 2012-03 ,pp. : 139-150

Karger

Access to resources Recommend Favorite

A Single Dose of Recombinant Activated Factor VII (NovoSeven®) Did Not Impair the Function of the Coronary Artery Bypass Grafts – Successful Treatment of Critical Bleeding after Cardiac Surgery in Two Cases

By  

Transfusion Medicine and Hemotherapy, Vol. 34, Iss. 3, 2007-05 ,pp. : 204-207

Karger

Access to resources Recommend Favorite

The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care

By Fewel Matthew E.   Park Paul  

Neurocritical Care, Vol. 1, Iss. 1, 2004-01 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite

Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated)

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite

Systemic Hemostasis With Recombinant-Activated Factor VII Followed by Local Thrombolysis With Recombinant Tissue Plasminogen Activator in Intraventricular Hemorrhage

By Ionita Catalina C.   Ferrara Joseph   McDonagh David L.   Grossi Peter   Graffagnino Carmelo  

Neurocritical Care, Vol. 3, Iss. 3, 2005-12 ,pp. : 246-248

Humana Press, Inc

Access to resources Recommend Favorite